Standard Biotools (LAB) EBT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.64 Bn | 221.57 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 144.47 Bn | 140.12 Bn | 3.61 Bn | 617.00 |
| 3 | Agilent Technologies | 40.90 Bn | 39.15 Bn | 1.04 Bn | 258.00 |
| 4 | Illumina | 30.90 Bn | 29.73 Bn | 770.00 Mn | -646.00 |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn | -82.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 2,922.00 |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | 1,974.00 |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -305.00 |
| 9 | 10x Genomics | 8.70 Bn | 8.14 Bn | 112.50 Mn | -3,374.00 |
| 10 | Standard Biotools | 282.88 Mn | -193.84 Mn | 10.54 Mn | -2,261.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,261.00 |
| Mar 31, 2026 | 4,704.00 |
| Dec 31, 2025 | 1,599.00 |
| Sep 30, 2025 | -6,956.00 |
| Jun 30, 2025 | 2,894.00 |
| Mar 31, 2025 | -4,582.00 |
| Dec 31, 2024 | -3,784.00 |
| Sep 30, 2024 | -1,613.00 |
| Jun 30, 2024 | -5,245.00 |
| Mar 31, 2024 | -433.00 |
| Dec 31, 2023 | 615.00 |
| Sep 30, 2023 | 3,494.00 |
| Jun 30, 2023 | 28,647.00 |
| Mar 31, 2023 | 22,400.00 |
| Sep 30, 2022 | -5,966.00 |
| Jun 30, 2022 | -28,719.00 |
| Mar 31, 2022 | -22,751.00 |
| Sep 30, 2021 | -4,220.00 |
| Jun 30, 2021 | -545.00 |
| Mar 31, 2021 | -216.00 |